North Growth Management’s West Pharmaceutical WST Stock Holding History

North Growth Management’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$22.4M	Hold	62,000	–	–	2.88%	8
2026 Q1	$15.6M	Buy	62,000 +23,000	+59%	+$5.72M	2.38%	12
2025 Q4	$10.8M	Buy	39,000 +5,000	+15%	+$1.37M	1.69%	23
2025 Q3	$8.93M	Buy	34,000 +5,000	+17%	+$1.22M	1.56%	30
2025 Q2	$6.36M	Buy	29,000 +4,000	+16%	+$855K	1.19%	32
2025 Q1	$5.49M	Buy	25,000 +7,000	+39%	+$1.93M	1.16%	35
2024 Q4	$5.96M	Sell	18,000 -1,000	-5%	-$315K	1.13%	36
2024 Q3	$5.56M	Buy	19,000 +3,000	+19%	+$919K	1.04%	38
2024 Q2	$5.16M	Hold	16,000	–	–	1.02%	39
2024 Q1	$6.19M	Buy	16,000 +4,000	+33%	+$1.48M	1.18%	40
2023 Q4	$4.34M	Buy	12,000 +2,000	+20%	+$708K	0.93%	41
2023 Q3	$3.61M	Hold	10,000	–	–	0.8%	41
2023 Q2	$3.75M	Hold	10,000	–	–	0.77%	41
2023 Q1	$3.4M	Buy	+10,000	New	+$2.92M	0.72%	41

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

North Growth Management's WST Position: Q2 2026 in Review

North Growth Management held its West Pharmaceutical (WST) position steady in Q2 2026 at 62,000 shares worth $22.4M. The position accounts for 2.88% of the portfolio, ranked #8.

North Growth Management first reported a position in WST in Q1 2023 and has held it in 14 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

North Growth Management held 62,000 shares of West Pharmaceutical worth $22.4M as of Q2 2026.
North Growth Management left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up 2.88% of North Growth Management's portfolio in Q2 2026, its #8 holding.
North Growth Management first reported a position in West Pharmaceutical in Q1 2023 and has held it in 14 quarters since.
830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on North Growth Management's 13F filing for Q2 2026, filed 22 Jul 2026.